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Summary: Arginase activity and free amino acids were measured in plasma, erythrocytes and leukocytes of patients
with hyperargininemia and in controls. There is no arginase activity in the leukocytes and erythrocytes of homozygous
patients; in heterozygotes it is normal to low. The activity is 50 to 100 times higher in leukocytes than in erythro-
cytes. In controls as well as in patients and heterozygotes, the amino acid concentrations are higher in leukocytes than
in plasma and erythrocytes. In addition to the increased arginine in the three blood compartments (the result of an
arginase deficiency), there is also an obvious decrease of aspartic acid in the erythrocytes of the patients. The arginine
concentration in leukocytes of heterozygotes is as high as in homozygotes and can therefore be used as a diagnostic
parameter for heterozygotes.
Arginase und freie Aminosäuren bei Hyperargininaemie: Arginin in Leukocyten als diagnostischer Hinweis auf
Heterozygote
Zusammenfassung: Arginase und freie Aminosäuren wurden in Plasma, Erythrocyten und Leukocyten von Patienten
mit Hyperargininaemie und Gesunden bestimmt. Arginase ist nicht nachweisbar in den Leukocyten und Erythrocyten
homozygoter Patienten; bei heterozygoten ist sie normal bis erniedrigt. Die Aktivität ist 50-100 mal höher in Leuko-
cyten als in Erythrocyteni Bei Gesunden als auch bei Patienten und Heterozygoten sind die Aminosäure-Konzentrationen
in den Leukocyten höher als in Plasma und Erythrocyten. Zusätzlich zum erhöhten Arginin in den drei Blutkompartiment
auf grund des Arginase-Mangels wurde auch ein klarer Abfall der Asparaginsäure in den Erythrocyten der Patienten ge-
funden. Die Argininkonzentration in Leukocyten Heterozygqter ist so hoch wie in Homozygoten und kann deshalb als
diagnostischer Hinweis auf Heterozygote gewertet werden.
Introduction 3.5.3.1) in tissues, e.g. in leukocytes, which are easy to
separate. We have also determine'd free amino acid con-
Hyperargininemia was characterised by the determination centrations and arginase activity in erythrocytes, in order
of amino acid concentrations in biological fluids, and to acquire a view of the free amino acid distribution in
enzyme activities in erythrqcytes (1, 2). But for a better the three blood compartments. This may provide infor-
understanding of the physiology, it is necessary to deter- mation on amino acid trasport across blood cell mem-
mine simultaneously free amino acids and arginase (EC branes, and amino acid metabolism within the blood cells.
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Although many studies have been done on the concen-
trations of free amino acids in plasma, relatively little is
known about their concentrations in blood cells. Soupart
(3) andMcMenamy et al (4) have reported general
studies on the amino acid concentrations in plasma,
erythrocytes and leukocytes in normal adults. Studies
on plasma and erythrocyte concentrations in normal
subjects and adult metabolic patients have been reported
by Levy et al (5) and h rnesjo et al (6). Quantitative
studies on the leukocytes of leukaemic patients and
patients with hypoproteinaemia were reported by Lee
et al (7) and Gupta et al (8).
It is not easy to compare the values from different
authors, owing to the different methods used and the
different ways of expressing the results. We have there-
fore expressed our results in jumol per volume and nmol
or μτηοΐ per quantity of cells. The amino acid levels also
depend on the methods of isolation and washing of the
blood cells (3,9).
Materials and Methods
Venous blood was obtained from 15 controls ), three sisters
affected with hyperargininemia, their heterozygous mother and
a heterozygous sister.
Isolation of leukocyte s and extraction of amino acids
About 10 ml heparinzed blood was diluted with 2.5 ml of a
50 g/1 Dextran 500 solution in 9 g/1 NaCl. This mixture was
allowed to stand for 45 minutes at room temperature. After
sedimentation of the red blood cells, the plasma-dextran frac-
tion, which contains the leukocytes, was carefully removed. Two
and a half volumes of a 8.7 g/1 NH4C1 solution were added to
this fraction. The samples were placed in a water bath at 37 °C .
for 10 minutes, then centrifuged directly at 156 g for 10 minutes
(Martin Christ, Type 03400, Osterode/Harz, W-Germany). The
supernatant was deproteinized by adding 50 mg 5-sulfosalicylic
acid in substance per ml plasma, then used for plasma amino
acid determination. The pellet was washed twice with 9 g/1 NaCl,
resuspended in 1 ml 9 g/1 NaCl and then counted with a hemo-
cytometer (W. Schreck, Type: Neubauer, Hofheim, W-Germany).
After counting, the cell suspension was lysed by freezing and
thawing, and homogenized (Braun, Potter S, Melsungen, W-Ger-
many). The lysed cells were deproteinized by adding 30 mg
5-sulfosalicylic acid in substance and centrifuged (Martin Christ,
Type UJ III KS, Osterode/Harz, W-Germany). The supernatant
was used for amino acid determinations.
Amino acid analysis
the plasma, erythrocytes and leukocyte supernatants from 10 ml
blood were lyophilized. The plasma, erythrocytes and leuko-
cyte amino acids were redissolved in 0.1 mol/1 HC1 and placed
on an amino acid analyzer (Technicon, Type: AAI, Dublin, Ire-
land). For amino acid determination in plasma a volume corre-
sponding to 0.5 ml plasma was applied to the column. About
2 · 1 7 leukocytes and 1010 erythrocytes were used for amino
acid analysis. To each sample, 250 nmol norleucine was added as
internal standard.
Measurement of arginase activity
Arginase activity was measured according to the method of
Azizi et al (10). the results (tab. 1) are given in μηιοί of urea
produced, by 109 cells, per minute at 37°C in 0.1 mol/1 argi-
nine at pH 10.14 (glycine buffer), after activation of the enzyme
for 20 min in 65 mmol/1 Mn2+ at 55 °C. Urea was measured by
the method of Marsh et al (11).
Results
Arginase activity in blood cells
In the controls, the arginase activity per cell was 50 to
100 times higher in leukocytes than in erythrocytes
(tab. 1). About the same ratio was found between leuko-
cyte and erythrocyte activity in the heterozygotes.
No arginase activity was found in erythrocytes and
leukocytes of the patients with hyperargininemia.
The arginase activity in the blood cells of heterozygotes
was normal to low.
Tab. 1. Arginase in erythrocytes and leukocytes of controls,
patients with hyperargininemia (A.W., M.W., I.W.),
their heterozygous mother and a heterozygous sister.














1) mean of 15 controls
2) standard deviation
Extraction of amino acids from erythrocytes
The sedimented erythrocytes were washed twice with 9 g/1
NaCl and counted with a hemocytometer. The cells were lysed
by adding 10 ml distilled water. The hemolysate was dep'ro-
teinized by adding 130 mg 5-sulfosalicylic acid in substance per
ml erythrocyte fraction, and centrifuged. The supernatant was
used for amino acid determinations.
*) The controls had no known relationship with individuals
carrying abnormalities of the urea cycle.
Free amino acids in plasma and blood cells
Arginine was increased in the plasma of patients with
hyperargininemia (tab. 2). Glutamine was also slightly
increased. Ornithine and lysine were decreased, while
threonirie and most of the essential arnino acids were
decreased only slightly. The other amino acids were near
to normal. The plasma arginine and ornithine values of
the heterozygotes were intermediate. Glutathione was
not detectable in plasma.
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Tab. 2. Free amino acid concentrations in plasma of controls, patients with hyperargininemia (I.W., A.W., M.W.), their hetero-





























































































































































































*) mean of 15 controls
2) standard deviation
3) not determined























































































































































































*) mean of 15 controls
2) standard deviation
3) not determined
The levels of arginine in erythrocytes (tab. 3) were
higher in the patients than in the controls arid hetero-
zygotes, Aspartic acid, Ornithine and lysine were
decreased, threonine only slightly. Glutathione was
present in high concentrations.
In leukocytes (tab. 4), the concentration of arginine was
higher in patients and heterozygotes than in controls.
However, the ofnithine level was normal.
Table 5 makes a comparison of the plasma ery throcy te
concentrations in controls and in hyperargininemia. In
the controls we observed much higher concentrations
of aspartic acid and glutathione in the erythrocytes.
Arginine and most of the essential amino acids were less
concentrated in erythrocytes. The concentration of the
other amino acids was more or less similar in plasma and
erythrocytes. The pattern was similar in the patients
with hyperargininemia, except for aspartic acid and
J. Clin. Chem. Clin. Biochem. / Vol. 17,1979 / No. 4
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Tab. 4. Free amino acid concentrations in leukocytes of controls, patients with hyperargininemia (I.W., A.W., M.W.), their heterozy-




































































































































































































*) mean of 15 controls
2) standard deviation
3) not determined











































































































































































































*) mean of 15 controls
2) standard deviation
3) not determined
arginine. The plasma/erythrocyte ratio in hyperargini-
nemia was much higher for aspartic acid and lower for
arginine than in the controls.
Table 6 gives a comparison of the amino acid concen-
tration in plasma, erythrocytes and leukocytes of ·
controls. The values are expressed in μιηοΐ per litre
plasma, litre erythrocytes and litre leukocytes. They
are obtained by taking the values of table 2 and table 3,
and by taking the mean erythrocytes volume as 87 fl.
The mean granulocyte volume was taken as 1022 fl.
For the lymphocyte and monocyte volumes, we used
1221 fl and 2145 fl respectively. Our isolation procedure
yielded the following fractions: 0.86 granulocytes, 0.12
lymphocytes and 0.02 monocytes. '
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Tab. 6. Free amino acid concentrations in plasma, erythrocytes and leukocytes of controls, (μτηοΐ/ΐ)














































































































































































*) mean of 15 controls
2) standard deviation














































































































































































*) mean of 15 controls
2) standard deviation3) calculated for a theoretical whole blood volume of 6 1, plasma volume of 3 1, erythrocytes volume of 3 1 and leukocytes volume of
60 ml.
Table 7 gives the distribution of the free amino acids
between the three blood compartments of the whole
blood reservoir in the controls. The values are calculated
by assuming the total mean blood volume to be 6 litres,
the plasma volume to be 3 litres, the erythrocyte
volume to be 3 litres, and the leukocytes volume to be
60ml.
Discussion
There is no arginase activity in the blood cells of patients
with hyperargininemia. In the blood cells of hetero-
zygotes, the activity is normal to low. The determination
of the enzyme activity in erythrocytes and leukocytes
could therefore only be used as a diagnostic parameter
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for homozygous patients, and not for heterozygotes.
The arginase activity in erythrocytes of heterozygotes
seems high enough to keep the arginine concentration
at a normal level; but this is not the case in the leuko-
cytes. The arginine concentration in the leukocytes of
heterozygotes is as high as in homozygotes. This could
be used as a diagnostic parameter for heterozygous ar-
ginase deficiency, providing this observation can be
confirmed in heterozygotes of other patients with hyper-
argininemia, independent of the heterogeneity ob^
served in the homozygous patients. For example,
hyperammonemia often is a diagnostic parameter for
homozygous patients, but three hyperargininemia
patients did not show hyperammonemia (12, 13,14) at
the time of diagnosis. Probably they showed periods of
hyperammonemia when they were younger.
Before interpreting the amino acid concentration values
we had to take into account the influence of washing
the blood cells with saline. As observed by Soupart (3),
some amino acids are lost into the saline washing
medium. This loss could explain the deviation of the
plasma/erythrocyte ratio from unity for some essential
amino acids, such as valine, methionine, isoleucine,
leucine and phenylalanine (tab. 5). Taking this fact into
account, we see that the concentration of most of the
amino acids is more or less similar in plasma and erythro-
cytes, both in controls, and in the patients with hyper-
argininemia.
However, glutathione and aspartic acid showed much
higher concentrations in the erythrocytes of the controls
In the erythrocytes of hyperargininemia, only glut-
athione shows a much higher concentration in com-
parison with the plasma. The plasma/erythrocyte ratio
for aspartic acid in patients with hyperargininemia is
much higher. The high concentration of aspartic acid
in erythrocytes of the controls could be explained by
intracellular "trapping", by intracellular deamination of
aspargine or by glutamic-oxalacetic transaminase
systems (3, 5). Normally, aspartic acid plays an im-
portant role in the regulation of the urea cycle. Mito-
chondrial aspartic acid is an inhibitor of carbamyl
phosphate synthetase (15). In cytoplasm, aspartic acid
is used as cosubstrate of arginino-succinate synthetase,
and in the pyrimidine synthesis. It is also used in the
biosynthesis of guanidinosuccinic acid (16). The
reason why^the aspartic acid values in erythrocytes of
patients with hyperargininemia fall to the plasma values
is not yet clear.
The relatively high concentration of glutathione in
erythrocytes is associated with the maintainance of
haemoglobin in its native, soluble form. Glutathione
could also play a role in the membrane transport of
amino acids (17).
A third group of amino acids, arginine and most of the
essential amino acids, is less concentrated in erythro-
cytes than in plasma. The plasma/erythrocyte ratio
for arginine is therefore higher than unity. One must
keep in mind that this ratio depends on the time taken
to separate the erythrocytes from the whole blood, i.e.
it depends on the time during which arginase might
further catabolize arginine in the erythrocytes.
In the controls and in hyperargininemia, the arnino acid
concentrations are higher in leukocytes than in the
plasma and erythrocytes (tab. 6). This was to be ex-
pected, since leukocytes are living cells, and it is known
that cells have much higher amino acid concentrations
than blood plasma (18). Taurine represents 50% of the
total free amino acid pool in leukocytes. Table 7 gives
us a better understanding of the distribution of the free
amino acids between the three blood compartments of
the whole blood reservoir.
When comparing the concentrations of free amino acids
in leukocytes of patients with hyperargininemia and
controls, the following points should be noted: our
controls are males, while the three patients with hyper^
argininemia, the heterozygous mother and a hetero-
zygous sister are females. Houpert (19) found that all
the amino acids, except taurine and ornithine, were
more concentrated in the leukocytes of women (tab. 4).
In fact only arginine is increased in the leukocytes of
the patients and heterozygotes. The other amino acids,
including ornithine, are quite normal.
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